Skip to main navigation Skip to search Skip to main content

The relative false negative rate of isosulfan blue in detecting sentinel lymph nodes in early breast cancer

  • Ramathibodi Hospital

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Objective: To determine the false negative rate of the isosulfan blue injection method of SLN detection in early breast cancer, relative to that of the combined blue dye and radiocolloid injection method. Material and Method: Seventy women with early breast cancer underwent the combined method of SLN detection during the period between September 2007 and December 2008. Standard criteria for each method were used to identify SLNs. Each SLN was labeled as identified by the blue dye, the radiocolloid and as being positive or negative for cancer cells. Results: Subjects were 50 years old with tumors of size 2.3 cm on the average. The average number of SLNs harvested was 2.5 nodes per subject. The detection rate for the isosulfan blue method was 91% (64/70). The relative false negative rate of the blue dye was zero (0/64). Conclusion: Experienced surgeons who use the isosulfan blue method of SLN detection in early breast cancer can be reasonably confident that the false negative rate of the isosulfan blue method was similar to that of the combined method.

Original languageEnglish
Pages (from-to)181-185
Number of pages5
JournalJournal of the Medical Association of Thailand
Volume95
Issue number2
Publication statusPublished - Feb 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Early breast cancer
  • False negative rate
  • Isosulfan blue
  • Sentinel lymph node biopsy

Fingerprint

Dive into the research topics of 'The relative false negative rate of isosulfan blue in detecting sentinel lymph nodes in early breast cancer'. Together they form a unique fingerprint.

Cite this